{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 113915
    }
  },
  "results": [
    {
      "safetyreportversion": "1",
      "safetyreportid": "10003589",
      "primarysourcecountry": "US",
      "occurcountry": "US",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "2",
      "serious": "1",
      "seriousnessother": "1",
      "receivedateformat": "102",
      "receivedate": "20140312",
      "receiptdateformat": "102",
      "receiptdate": "20140312",
      "fulfillexpeditecriteria": "1",
      "companynumb": "US-US-EMD SERONO, INC.-7274353",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "EMD SERONO INC",
        "duplicatenumb": "US-US-EMD SERONO, INC.-7274353"
      },
      "primarysource": {
        "reportercountry": "US",
        "qualification": "5"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "63",
        "patientonsetageunit": "801",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Loss of consciousness",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Fall",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Gait disturbance",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Convulsion",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Influenza",
            "reactionoutcome": "2"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Speech disorder",
            "reactionoutcome": "6"
          },
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Malaise",
            "reactionoutcome": "6"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "REBIF",
            "drugbatchnumb": "AU008268",
            "drugauthorizationnumb": "103780",
            "drugstructuredosagenumb": "44",
            "drugstructuredosageunit": "004",
            "drugseparatedosagenumb": "3",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "803",
            "drugdosageform": "INJECTION",
            "drugadministrationroute": "058",
            "drugindication": "MULTIPLE SCLEROSIS",
            "drugstartdateformat": "102",
            "drugstartdate": "20130902",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "BLA103780"
              ],
              "brand_name": [
                "REBIF"
              ],
              "generic_name": [
                "INTERFERON BETA-1A"
              ],
              "manufacturer_name": [
                "EMD Serono, Inc."
              ],
              "product_ndc": [
                "44087-0022",
                "44087-8822",
                "44087-0188",
                "44087-0044",
                "44087-3322",
                "44087-3344"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "substance_name": [
                "INTERFERON BETA-1A"
              ],
              "rxcui": [
                "758025",
                "758027",
                "758028",
                "758029",
                "758030",
                "758032",
                "795748",
                "795749",
                "1649994",
                "1649996",
                "1650003",
                "1650004",
                "1650011",
                "1650012",
                "1650268",
                "1650282"
              ],
              "spl_id": [
                "037d2645-544b-41bb-bea8-00b578366ac6"
              ],
              "spl_set_id": [
                "c6fcb5d2-8fcd-44fa-a838-b84ee5f44f0f"
              ],
              "package_ndc": [
                "44087-8822-1",
                "44087-0188-1",
                "44087-0022-9",
                "44087-0022-3",
                "44087-0044-9",
                "44087-0044-3",
                "44087-3322-9",
                "44087-3322-1",
                "44087-3344-9",
                "44087-3344-1"
              ],
              "nui": [
                "M0025715",
                "N0000191625"
              ],
              "pharm_class_cs": [
                "Interferon-beta [CS]"
              ],
              "pharm_class_epc": [
                "Interferon beta [EPC]"
              ],
              "unii": [
                "XRO4566Q4R"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ZOLOFT                             /01011401/",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "COMPAZINE                          /00013302/",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "OXYCODONE",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "openfda": {
              "application_number": [
                "ANDA203638",
                "NDA208090"
              ],
              "brand_name": [
                "OXYCODONE HYDROCHLORIDE",
                "XTAMPZA ER"
              ],
              "generic_name": [
                "OXYCODONE"
              ],
              "manufacturer_name": [
                "Amneal Pharmaceuticals LLC",
                "Collegium Pharmaceutical, Inc."
              ],
              "product_ndc": [
                "65162-047",
                "65162-048",
                "65162-049",
                "65162-050",
                "65162-051",
                "24510-110",
                "24510-115",
                "24510-120",
                "24510-130",
                "24510-140"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "OXYCODONE HYDROCHLORIDE",
                "OXYCODONE"
              ],
              "rxcui": [
                "1049611",
                "1049618",
                "1049621",
                "1049683",
                "1049686",
                "1790527",
                "1790533",
                "1791558",
                "1791560",
                "1791567",
                "1791569",
                "1791574",
                "1791576",
                "1791580",
                "1791582"
              ],
              "spl_id": [
                "8b9e3253-7735-44cc-a59b-3125ab573c84",
                "fda0989d-9319-4e35-af83-fca1ec66878e"
              ],
              "spl_set_id": [
                "094b64b3-cd32-4de5-afb6-ea00d9caad74",
                "b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c"
              ],
              "package_ndc": [
                "65162-047-03",
                "65162-047-10",
                "65162-047-25",
                "65162-047-50",
                "65162-048-03",
                "65162-048-10",
                "65162-048-25",
                "65162-049-03",
                "65162-049-10",
                "65162-049-25",
                "65162-049-50",
                "65162-050-03",
                "65162-050-10",
                "65162-050-25",
                "65162-051-03",
                "65162-051-10",
                "65162-051-25",
                "65162-051-50",
                "24510-110-10",
                "24510-110-20",
                "24510-115-10",
                "24510-115-20",
                "24510-120-10",
                "24510-120-20",
                "24510-130-10",
                "24510-130-20",
                "24510-140-10",
                "24510-140-20"
              ],
              "unii": [
                "C1ENJ2TE6C",
                "CD35PMG570"
              ],
              "nui": [
                "N0000175684",
                "N0000175690"
              ],
              "pharm_class_moa": [
                "Full Opioid Agonists [MoA]"
              ],
              "pharm_class_epc": [
                "Opioid Agonist [EPC]"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HYDROCODONE",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ABILIFY",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "openfda": {
              "application_number": [
                "NDA021436"
              ],
              "brand_name": [
                "ABILIFY"
              ],
              "generic_name": [
                "ARIPIPRAZOLE"
              ],
              "manufacturer_name": [
                "Otsuka America Pharmaceutical, Inc."
              ],
              "product_ndc": [
                "59148-006",
                "59148-007",
                "59148-008",
                "59148-009",
                "59148-010",
                "59148-011"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "ARIPIPRAZOLE"
              ],
              "rxcui": [
                "349490",
                "349545",
                "349547",
                "349553",
                "352307",
                "352308",
                "352309",
                "352310",
                "402131",
                "404602",
                "602964",
                "615172"
              ],
              "spl_id": [
                "1b189d15-798d-4bed-a93d-a543ed7abd81"
              ],
              "spl_set_id": [
                "c040bd1d-45b7-49f2-93ea-aed7220b30ac"
              ],
              "package_ndc": [
                "59148-006-13",
                "59148-006-92",
                "59148-007-13",
                "59148-007-35",
                "59148-007-94",
                "59148-008-13",
                "59148-008-35",
                "59148-008-95",
                "59148-009-13",
                "59148-009-35",
                "59148-009-95",
                "59148-010-13",
                "59148-010-35",
                "59148-011-13",
                "59148-011-35"
              ],
              "nui": [
                "N0000175430"
              ],
              "pharm_class_epc": [
                "Atypical Antipsychotic [EPC]"
              ],
              "unii": [
                "82VFR53I78"
              ]
            }
          }
        ]
      }
    }
  ]
}